Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News New blood cancer test ‘can help predict treatment outcomes’

New blood cancer test ‘can help predict treatment outcomes’

5th October 2015

Australian researchers have developed a world-first test that could be used to help direct treatment choices for patients with certain forms of blood cancer.

Created by the University of Queensland Diamantina Institute, the tool is able to predict how patients with a specific form of non-Hodgkin's lymphoma – called diffuse large B-cell lymphoma – will respond to standard treatment.

By ensuring that patients always receive the most suitable treatment for them, the test could significantly reduce relapse rates and have a significant impact on how drugs are funded.

Researchers are seeking a provisional patent for the test and will be working with commercial partners to develop the technology further.

Professor Maher Gandhi of the University of Queensland Diamantina Institute said: "The test will allow clinicians like myself to determine which patients are unlikely to respond well to standard treatment, thus avoiding ineffective and unnecessary chemotherapy and prompting consideration of other treatment options."

Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma, with between 4,500 and 5,000 people diagnosed with the condition each year in the UK.ADNFCR-8000103-ID-801802336-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.